Meyka Pro banner
Hyperfine, Inc.

Hyperfine, Inc. Fundamental Analysis

HYPRNASDAQ
HealthcareMedical - Specialties
$0.99
$0.01(1.32%)
U.S. Market opens in 11h 23m

Hyperfine, Inc. Fundamental Analysis

Hyperfine, Inc. (HYPR) shows weak financial fundamentals with a PE ratio of -2.42, profit margin of -2.27%, and ROE of -1.01%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position42.10%
PEG Ratio-0.09
Current Ratio5.52

Areas of Concern

ROE-1.01%
Operating Margin-2.27%
We analyze HYPR's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -307.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-307.2/100

We analyze HYPR's fundamental strength across five key dimensions:

Efficiency Score

Weak

HYPR struggles to generate sufficient returns from assets.

ROA > 10%
-57.64%

Valuation Score

Excellent

HYPR trades at attractive valuation levels.

PE < 25
-2.42
PEG Ratio < 2
-0.09

Growth Score

Weak

HYPR faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

HYPR maintains a strong and stable balance sheet.

Debt/Equity < 1
0.39
Current Ratio > 1
5.52

Profitability Score

Weak

HYPR struggles to sustain strong margins.

ROE > 15%
-101.28%
Net Margin ≥ 15%
-2.27%
Positive Free Cash Flow
No

Key Financial Metrics

Is HYPR Expensive or Cheap?

P/E Ratio

HYPR trades at -2.42 times earnings. This suggests potential undervaluation.

-2.42

PEG Ratio

When adjusting for growth, HYPR's PEG of -0.09 indicates potential undervaluation.

-0.09

Price to Book

The market values Hyperfine, Inc. at 2.84 times its book value. This may indicate undervaluation.

2.84

EV/EBITDA

Enterprise value stands at -3.37 times EBITDA. This is generally considered low.

-3.37

How Well Does HYPR Make Money?

Net Profit Margin

For every $100 in sales, Hyperfine, Inc. keeps $-2.27 as profit after all expenses.

-2.27%

Operating Margin

Core operations generate -2.27 in profit for every $100 in revenue, before interest and taxes.

-2.27%

ROE

Management delivers $-1.01 in profit for every $100 of shareholder equity.

-1.01%

ROA

Hyperfine, Inc. generates $-57.64 in profit for every $100 in assets, demonstrating efficient asset deployment.

-57.64%

Following the Money - Real Cash Generation

Operating Cash Flow

Hyperfine, Inc. generates limited operating cash flow of $-23.88M, signaling weaker underlying cash strength.

$-23.88M

Free Cash Flow

Hyperfine, Inc. generates weak or negative free cash flow of $-24.71M, restricting financial flexibility.

$-24.71M

FCF Per Share

Each share generates $-0.29 in free cash annually.

$-0.29

FCF Yield

HYPR converts -33.70% of its market value into free cash.

-33.70%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.42

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.09

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.84

vs 25 benchmark

P/S Ratio

Price to sales ratio

5.49

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.39

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.52

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.01

vs 25 benchmark

ROA

Return on assets percentage

-0.58

vs 25 benchmark

ROCE

Return on capital employed

-0.69

vs 25 benchmark

How HYPR Stacks Against Its Sector Peers

MetricHYPR ValueSector AveragePerformance
P/E Ratio-2.4229.43 Better (Cheaper)
ROE-101.28%426.00% Weak
Net Margin-226.88%-11473.00% (disorted) Weak
Debt/Equity0.390.79 Strong (Low Leverage)
Current Ratio5.525.14 Strong Liquidity
ROA-57.64%-17.00% (disorted) Weak

HYPR outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Hyperfine, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ